Gemtuzumab ozogamicin is efficacious in attaining complete remission in relapsed/refractory acute leukemia prior to hematopoietic cell transplant: A case series

par Giancarlo Fatobene, Gabriela Rodriguez de Souza, Celso Arrais Rodrigues, Yana Augusta Sarkis Novis, Vanderson Rocha
Publié 2021

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell ther...

par Rodrigo Nalio Ramos, Virginia Picanço-Castro, Theo Gremen M. Oliveira, Alfredo Mendrone, Junior, Gil Cunha De Santis, Martin Hernan Bonamino, Vanderson Rocha
Publié 2021

Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation

par Vinícius Campos de Molla, Vitor Heidrich, Julia Stephanie Bruno, Franciele Hinterholz Knebel, Wanessa Miranda-Silva, Paula Fontes Asprino, Luciana Tucunduva, Vanderson Rocha, Yana Novis, Anamaria Aranha Camargo, Eduardo Rodrigues Fregnani, Celso Arrais-Rodrigues
Publié 2021

Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome

par Juan L. Coelho-Silva, Douglas R. A. Silveira, Diego A. Pereira-Martins, Cesar A. O. Rojas, Antonio R. Lucena-Araujo, Eduardo M. Rego, João A. Machado-Neto, Israel Bendit, Vanderson Rocha, Fabiola Traina
Publié 2021

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leuk...

par Adriana Seber, Claudio Galvão de CastroJunior, Lucila N. Kerbauy, Alexandre V. Hirayama, Carmem Bonfim, Juliana Folloni Fernandes, Mair Souza, Rony Schafell, Samir Nabhan, Sandra Regina Loggetto, Belinda Pinto Simões, Vanderson Rocha, Marcos de Lima, Renato L. Guerino-Cunha, Henrique Bittencourt
Publié 2021

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphom...

par Alvaro J. Alencar, Alexandre V. Hirayama, Diego V. Clé, Marco Aurélio Salvino, Guilherme Perini, Celso Arrais, Otávio Baiocchi, Leonardo Carvalho Palma, Iago Colturato, Jorge Vaz, Ricardo Chiattone, Marcos de Lima, Jayr Schmidt Filho, Samir Nabhan, Vanderson Rocha, Renato L. Guerino-Cunha, Carlos S. Chiattone
Publié 2021